Thioredoxin-Interacting Protein: A Potential Therapeutic Target for Treatment of Progressive Fibrosis in Diabetic Nephropathy

Nephron

Volumn 129, Issue 2, 2015, Pages 109-127

  Tan, Christina Y R ^a   Weier, Qi ^a   Zhang, Yuan ^a   Cox, Alison J ^a   Kelly, Darren J ^a   Langham, Robyn G ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

Diabetic nephropathy; Oxidative stress; Tubulo interstitial fibrosis; TXNIP; TXNIP deoxyribozyme

Indexed keywords

CARRIER PROTEIN; COLLAGEN TYPE 4; GLUCOSE BLOOD LEVEL; NOD-LIKE RECEPTOR 3, RAT; TXNIP PROTEIN, HUMAN;

ANIMAL; COMPLICATION; DIABETIC NEPHROPATHIES; DISEASE COURSE; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; FEMALE; FIBROSIS; GLOMERULUS; GLUCOSE BLOOD LEVEL; KIDNEY; KIDNEY FUNCTION TEST; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; RAT;

ANIMALS; BLOOD GLUCOSE; CARRIER PROTEINS; COLLAGEN TYPE IV; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE PROGRESSION; FEMALE; FIBROSIS; KIDNEY; KIDNEY FUNCTION TESTS; KIDNEY GLOMERULUS; OXIDATIVE STRESS; RATS;

EID: 84949548685     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000368238     Document Type: Article

References (47)

1. Nishiyama A, Matsui M, Iwata S, et al: Identification of thioredoxin-binding protein-2/Vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 1999; 274: 21645-21650.
2. Chen KS, DeLuca HF: Isolation and characterization of a novel cDNA from HL-60 cells treated with 1,25-dihydroxyVitamin D-3. Biochim Biophys Acta 1994; 1219: 26-32.
3. Cheng GC, Schulze PC, Lee RT, Sylvan J, Zetter BR, Huang H: Oxidative stress and thioredoxin-interacting protein promote intravasation of melanoma cells. Exp Cell Res 2004; 300: 297-307.
4. Kim KY, Shin SM, Kim JK, Paik SG, Yang Y, Choi I: Heat shock factor regulates VDUP1 gene expression. Biochem Biophys Res Commun 2004; 315: 369-375.
5. Wang Y, De Keulenaer GW, Lee RT: Vitamin D(3)-up-regulated protein-1 is a stress-responsive gene that regulates cardiomyocyte viability through interaction with thioredoxin. J Biol Chem 2002; 277: 26496-26500.
6. Shalev A, Pise-Masison CA, Radonovich M, et al: Oligonucleotide microarray analysis of intact human pancreatic islets: identification of glucose-responsive genes and a highly regulated TGFbeta signaling pathway. Endocrinology 2002; 143: 3695-3698.
7. Hirota T, Okano T, Kokame K, Shirotani-Ikejima H, Miyata T, Fukada Y: Glucose downregulates Per1 and Per2 mRNA levels and induces circadian gene expression in cultured Rat-1 fibroblasts. J Biol Chem 2002; 277: 44244-44251.
8. Cheng DW, Jiang Y, Shalev A, Kowluru R, Crook ED, Singh LP: An analysis of high glucose and glucosamine-induced gene expression and oxidative stress in renal mesangial cells. Arch Physiol Biochem 2006; 112: 189-218.
9. Qi W, Chen X, Gilbert RE, et al: High glucoseinduced thioredoxin-interacting protein in renal proximal tubule cells is independent of transforming growth factor-beta1. Am J Pathol 2007; 171: 744-754.
10. Junn E, Han SH, Im JY, et al: Vitamin D3 upregulated protein 1 mediates oxidative stress via suppressing the thioredoxin function. J Immunol 2000; 164: 6287-6295.
11. Patwari P, Higgins LJ, Chutkow WA, Yoshioka J, Lee RT: The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange. J Biol Chem 2006; 281: 21884-21891.
12. Schulze PC, Yoshioka J, Takahashi T, He Z, King GL, Lee RT: Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J Biol Chem 2004; 279: 30369-30374.
13. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J: Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 2010; 11: 136-140.
14. Patwari P, Chutkow WA, Cummings K, et al: Thioredoxin-independent regulation of metabolism by the alpha-arrestin proteins. J Biol Chem 2009; 284: 24996-25003.
15. Watanabe R, Nakamura H, Masutani H, Yodoi J: Anti-oxidative, anti-cancer and anti-inflammatory actions by thioredoxin 1 and thioredoxin-binding protein-2. Pharmacol Ther 2010; 127: 261-270.
16. Kobayashi T, Uehara S, Ikeda T, Itadani H, Kotani H: Vitamin D3 up-regulated protein-1 regulates collagen expression in mesangial cells. Kidney Int 2003; 64: 1632-1642.
17. Advani A, Gilbert RE, Thai K, et al: Expression, localization, and function of the thioredoxin system in diabetic nephropathy. J Am Soc Nephrol 2009; 20: 730-741.
18. Hamada Y, Fukagawa M: A possible role of thioredoxin interacting protein in the pathogenesis of streptozotocin-induced diabetic nephropathy. Kobe J Med Sci 2007; 53: 53-61.
19. Wu J, Lin H, Liu D, et al: The protective effect of telmisartan in type 2 diabetes rat kidneys is related to the downregulation of thioredoxininteracting protein. J Endocrinol Invest 2013; 36: 453-459.
20. Qi W, Chen X, Twigg S, Polhill TS, Gilbert RE, Pollock CA: Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells. Kidney Int 2006; 69: 989-995.
21. Xiang G, Seki T, Schuster MD, et al: Catalytic degradation of Vitamin D up-regulated protein 1. mRNA enhances cardiomyocyte survival and prevents left ventricular remodeling after myocardial ischemia. J Biol Chem 2005; 280: 39394-39402.
22. Santoro SW, Joyce GF: A general purpose RNA-cleaving DNA enzyme. Proc Natl Acad Sci U S A 1997; 94: 4262-4266.
23. Bhindi R, Fahmy RG, Lowe HC, et al: Brothers in arms: DNA enzymes, short interfering RNA, and the emerging wave of smallmolecule nucleic acid-based gene-silencing strategies. Am J Pathol 2007; 171: 1079-1088.
24. Bunag RD: Validation in awake rats of a tailcuff method for measuring systolic pressure. J Appl Physiol 1973; 34: 279-282.
25. Kelly DJ, Edgley AJ, Zhang Y, et al: Protein kinase C-beta inhibition attenuates the progression of nephropathy in non-diabetic kidney disease. Nephrol Dial Transplant 2009; 24: 1782-1790.
26. Kelly DJ, Wilkinson-Berka JL, Allen TJ, Cooper ME, Skinner SL: A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat (TGR). Kidney Int 1998; 54: 343-352.
27. Saito T, Sumithran E, Glasgow EF, Atkins RC: The enhancement of aminonucleoside nephrosis by the co-administration of protamine. Kidney Int 1987; 32: 691-699.
28. Qi W, Chen X, Gilbert RE, et al: High glucoseinduced thioredoxin-interacting protein in renal proximal tubule cells is independent of transforming growth factor-beta1. Am J Pathol 2007; 171: 744-754.
29. Tan SM, Zhang Y, Connelly KA, Gilbert RE, Kelly DJ: Targeted inhibition of activin receptor-like kinase 5 (ALK5) signaling attenuates cardiac dysfunction following myocardial infarction. Am J Physiol Heart Circ Physiol 2010;298:H1415-H1425.
30. Tan SM, Zhang Y, Cox AJ, Kelly DJ, Qi W: Tranilast attenuates the up-regulation of thioredoxin-interacting protein and oxidative stress in an experimental model of diabetic nephropathy. Nephrol Dial Transplant 2011; 26: 100-110.
31. Kelly DJ, Gilbert RE, Cox AJ, Soulis T, Jerums G, Cooper ME: Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy. J Am Soc Nephrol 2001; 12: 2098-2107.
32. Gilbert RE, Cooper ME: The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney Int 1999; 56: 1627-1637.
33. Leo CH, Hart JL, Woodman OL: Impairment of both nitric oxide-mediated and EDHFtype relaxation in small mesenteric arteries from rats with streptozotocin-induced diabetes. Br J Pharmacol 2011; 162: 365-377.
34. Perrone L, Devi TS, Hosoya K, Terasaki T, Singh LP: Thioredoxin interacting protein (TXNIP) induces inflammation through chromatin modification in retinal capillary endothelial cells under diabetic conditions. J Cell Physiol 2009; 221: 262-272.
35. Perrone L, Devi TS, Hosoya KI, Terasaki T, Singh LP: Inhibition of TXNIP expression in vivo blocks early pathologies of diabetic retinopathy. Cell Death Dis 2010; 1:e65.
36. Rappaport J, Hanss B, Kopp JB, et al: Transport of phosphorothioate oligonucleotides in kidney: implications for molecular therapy. Kidney Int 1995; 47: 1462-1469.
37. Butler M, Stecker K, Bennett CF: Cellular distribution of phosphorothioate oligodeoxynucleotides in normal rodent tissues. Lab Invest 1997; 77: 379-388.
38. Gnudi L: Cellular and molecular mechanisms of diabetic glomerulopathy. Nephrol Dial Transplant 2012; 27: 2642-2649.
39. Baud L, Nivez MP, Chansel D, Ardaillou R: Stimulation by oxygen radicals of prostaglandin production by rat renal glomeruli. Kidney Int 1981; 20: 332-339.
40. Lewis MS, Whatley RE, Cain P, McIntyre TM, Prescott SM, Zimmerman GA: Hydrogen peroxide stimulates the synthesis of plateletactivating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. J Clin Invest 1988; 82: 2045-2055.
41. Hughes AK, Stricklett PK, Padilla E, Kohan DE: Effect of reactive oxygen species on endothelin-1. production by human mesangial cells. Kidney Int 1996; 49: 181-189.
42. Trachtman H, Futterweit S, Singhal P: Nitric oxide modulates the synthesis of extracellular matrix proteins in cultured rat mesangial cells. Biochem Biophys Res Commun 1995; 207: 120-125.
43. Shah A, Xia L, Goldberg H, Lee KW, Quaggin SE, Fantus IG: Thioredoxin-interacting protein mediates high glucose-induced reactive oxygen species generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells. J Biol Chem 2013; 288: 6835-6848.
44. Wang XQ, Nigro P, World C, Fujiwara K, Yan C, Berk BC: Thioredoxin interacting protein promotes endothelial cell inflammation in response to disturbed flow by increasing leukocyte adhesion and repressing Kruppel-like factor 2. Circ Res 2012; 110: 560-568.
45. Yoshioka J, Chutkow WA, Lee S, et al: Deletion of thioredoxin-interacting protein in mice impairs mitochondrial function but protects the myocardium from ischemia-reperfusion injury. J Clin Invest 2012; 122: 267-279.
46. Patwari P, Lee RT: An expanded family of arrestins regulate metabolism. Trends Endocrinol Metab 2012; 23: 216-222.
47. Davis BK, Ting JP: NLRP3 has a sweet tooth. Nat Immunol 2010; 11: 105-106.